Panel Discussion | Who Should Get MCS for High-Risk PCI? Pros and Cons

Sunday, March 8, 2026

3:35 PM - 3:55 PM EST

Location: CRT Center Stage

Moderator(s)

Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

Disclosure(s): No financial relationships to disclose
David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure information not submitted.

Panel Discussant(s)

Fayaz Shawl, MD, FACC, FACP, FSCAI

Director, Interventional Cardiology
Adventist HeathCare WhiteOak Medical Center
Silver Spring , Maryland, United States

Disclosure(s): No financial relationships to disclose
Itsik Ben-Dor, MD

WHC
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Abdulla A. Damluji, MD, PhD, MBA

Interventional Cardiologist
Cleveland Clinic Foundation
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Arnav Kumar, MD, MSCR

Interventional Cardiologist Structural Heart Valve Specialist Assistant Professor of Medicine
University of Houston, HCA Medical Center
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose
John M. Lasala, MD, PhD, MSCAI

Professor of Medicine; Director, Structural Heart Disease Program
Washington University School of Medicine
St. Louis, Missouri, United States

Disclosure information not submitted.
Hady Lichaa, MD

Interventional Cardiovascular Specialist
Ascension Saint Thomas Hospital
Murfreesboro, Tennessee, United States

Disclosure(s): Medtronic, Surmodics, Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing)
Rajesh Sachdeva, MD, FACC, FSCAI

Associate Professor of Medicine
Emory University School of Medicine, Georgia, United States

Disclosure(s): No financial relationships to disclose
Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)
Joseph L. Thomas, MD

Chair, Department of Medicine
Harbor UCLA Medical Center
TORRANCE, California, United States

Disclosure information not submitted.

Disclosure(s):

Lindsey Cilia, MD: No financial relationships to disclose

Fayaz Shawl, MD, FACC, FACP, FSCAI: No financial relationships to disclose

Itsik Ben-Dor, MD: No financial relationships to disclose

Abdulla A. Damluji, MD, PhD, MBA: No financial relationships to disclose

Arnav Kumar, MD, MSCR: No financial relationships to disclose

Hady Lichaa, MD: Medtronic, Surmodics, Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing)

Rajesh Sachdeva, MD, FACC, FSCAI: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)